CNS Injury: Posttranslational Modification of the Tau Protein as a Biomarker.

Related Articles

CNS Injury: Posttranslational Modification of the Tau Protein as a Biomarker.

Neuroscientist. 2017 Nov 01;:1073858417742125

Authors: Caprelli MT, Mothe AJ, Tator CH

Abstract
The ideal biomarker for central nervous system (CNS) trauma in patients would be a molecular marker specific for injured nervous tissue that would provide a consistent and reliable assessment of the presence and severity of injury and the prognosis for recovery. One candidate biomarker is the protein tau, a microtubule-associated protein abundant in the axonal compartment of CNS neurons. Following axonal injury, tau becomes modified primarily by hyperphosphorylation of its various amino acid residues and cleavage into smaller fragments. These posttrauma products can leak into the cerebrospinal fluid or bloodstream and become candidate biomarkers of CNS injury. This review examines the primary molecular changes that tau undergoes following traumatic brain injury and spinal cord injury, and reviews the current literature in traumatic CNS biomarker research with a focus on the potential for hyperphosphorylated and cleaved tau as sensitive biomarkers of injury.

PMID: 29283022 [PubMed - as supplied by publisher]

http://ift.tt/2EbJ2In